About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
35
By Phase
PHASE2: 1PHASE1/PHASE2: 2PHASE1: 1
By Status
WITHDRAWN: 2TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT02939807Collaborator
A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma
PHASE2Withdrawn
Started: Sep 30, 2019 · Completed: Jan 30, 2024
NCT02757326Collaborator
ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
PHASE1/PHASE2Terminated
13 participants
Started: Dec 13, 2016 · Completed: May 31, 2019
NCT02229981Collaborator
Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma
PHASE1/PHASE2Withdrawn
Started: Jul 31, 2014 · Completed: Dec 31, 2019
NCT01488513Collaborator
ABC294640 in Treating Patients With Advanced Solid Tumors
PHASE1Completed
22 participants
Started: Aug 31, 2011 · Completed: Jul 31, 2015
Locations (1)
Headquarters
Hummelstown, PA, United States
Map
Loading map...